Abvc Biopharma ABVC
NASDAQ ABVC
$0.88 -0.02 (-2.69%)
As of: Aug 21, 2026 · 1:24 PM EDT

Abvc Biopharma (ABVC) Debt Ratio (2014 - 2026)

Abvc Biopharma's (ABVC) quarterly Debt Ratio came in at 0.0 in Q1 2026, down 95.7% YoY from 0.1 in Q1 2025, and down 87.46% on a QoQ basis from 0.04 in Q4 2025.

Abvc Biopharma (ABVC) Debt Ratio (2014 - 2026) Analysis & Trends

Abvc Biopharma (ABVC) has 12 years of Debt Ratio data on file, last reported at 0.0 in Q1 2026.

  • Quarterly Debt Ratio fell 95.7% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (down 95.7% YoY) and the FY2025 annual result came in at 0.04, down 67.81% from the prior year.
  • Debt Ratio fell to 0.0 in Q1 2026, from 0.04 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.2 in Q4 2022 to a low of 0.0 in Q1 2026.
  • A 5-year average of 0.08 and a median of 0.1 in 2025 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio jumped 159.52% — and 2026, when it plunged 95.7%.
  • Tracing ABVC's Debt Ratio over 5 years: stood at 0.2 in 2022, then plunged by 32.19% to 0.13 in 2023, then dropped by 16.87% to 0.11 in 2024, then plunged by 67.81% to 0.04 in 2025, then plunged by 87.46% to 0.0 in 2026.
  • The last three Debt Ratio figures came in at 0.0 (Q1 2026), 0.04 (Q4 2025), and 0.06 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.35 Bn 131.49 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.24 Bn 78.25 Bn 3.93 Bn 0.05
3 Argenx Se 65.26 Bn 60.08 Bn 1.37 Bn -
4 Moderna 58.83 Bn 53.69 Bn 52.00 Mn 0.05
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.68 Bn 28.37 Bn 992.69 Mn -
7 BioNTech SE 27.95 Bn 9.56 Bn 668.28 Mn 0.03
8 Insmed 27.50 Bn 26.34 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.44 Bn - 0.47
10 Abvc Biopharma 22.82 Mn 22.82 Mn - 0.00

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Mar 31, 2026 0.00
Dec 31, 2025 0.04
Sep 30, 2025 0.06
Jun 30, 2025 0.11
Mar 31, 2025 0.10
Dec 31, 2024 0.11
Sep 30, 2024 0.12
Jun 30, 2024 0.11
Mar 31, 2024 0.11
Dec 31, 2023 0.13
Sep 30, 2023 0.05
Dec 31, 2022 0.20
Sep 30, 2022 0.04
Jun 30, 2022 0.03
Mar 31, 2022 0.04
Dec 31, 2021 0.08
Sep 30, 2021 0.03
Jun 30, 2021 0.21
Mar 31, 2021 0.18